- Home
- PFSI vs BSX Comparison
PFSI vs BSX Comparison
Compare PFSI & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PFSI
- BSX
- Stock Information
- Founded
- PFSI 2008
- BSX 1979
- Country
- PFSI United States
- BSX United States
- Employees
- PFSI N/A
- BSX N/A
- Industry
- PFSI Finance: Consumer Services
- BSX Medical/Dental Instruments
- Sector
- PFSI Finance
- BSX Health Care
- Exchange
- PFSI Nasdaq
- BSX Nasdaq
- Market Cap
- PFSI 5.4B
- BSX 157.6B
- IPO Year
- PFSI 2013
- BSX 1992
- Fundamental
- Price
- PFSI $127.49
- BSX $97.80
- Analyst Decision
- PFSI Buy
- BSX Strong Buy
- Analyst Count
- PFSI 7
- BSX 22
- Target Price
- PFSI $120.14
- BSX $118.91
- AVG Volume (30 Days)
- PFSI 421.8K
- BSX 7.8M
- Earning Date
- PFSI 10-21-2025
- BSX 10-22-2025
- Dividend Yield
- PFSI 0.94%
- BSX N/A
- EPS Growth
- PFSI 97.42
- BSX 36.90
- EPS
- PFSI 7.22
- BSX 1.68
- Revenue
- PFSI $3,571,340,000.00
- BSX $18,494,000,000.00
- Revenue This Year
- PFSI N/A
- BSX $19.75
- Revenue Next Year
- PFSI $23.52
- BSX $11.03
- P/E Ratio
- PFSI $17.62
- BSX $58.59
- Revenue Growth
- PFSI 65.89
- BSX 21.44
- 52 Week Low
- PFSI $85.74
- BSX $80.64
- 52 Week High
- PFSI $130.02
- BSX $109.50
- Technical
- Relative Strength Index (RSI)
- PFSI 80.73
- BSX 27.06
- Support Level
- PFSI $122.70
- BSX $104.24
- Resistance Level
- PFSI $130.02
- BSX $109.50
- Average True Range (ATR)
- PFSI 3.34
- BSX 2.15
- MACD
- PFSI 0.74
- BSX -1.07
- Stochastic Oscillator
- PFSI 88.64
- BSX 5.19
About PFSI PennyMac Financial Services Inc.
PennyMac Financial Services Inc is a specialty financial services firm with a comprehensive mortgage platform and integrated business focused on the production and servicing of U.S. residential mortgage loans. The company operates through two segments: production and servicing. The production segment performs loan origination, acquisition and sale activities. The servicing segment performs loan servicing for newly originated loans.
About BSX Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.